NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA

Two Additional Phase I Studies in Lung and Esophageal Cancer Pending

https://www.financialbuzz.com/nanobiotix-announces-first-patient-injected-with-nbtxr3-in-pancreatic-cancer-and-safe-to-proceed-notifications-for-two-additional-trials-from-u-s-fda/

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *